DE68918453T2 - Zusammensetzungen auf Basis von CPF Peptiden sowie deren Verwendungen. - Google Patents

Zusammensetzungen auf Basis von CPF Peptiden sowie deren Verwendungen.

Info

Publication number
DE68918453T2
DE68918453T2 DE68918453T DE68918453T DE68918453T2 DE 68918453 T2 DE68918453 T2 DE 68918453T2 DE 68918453 T DE68918453 T DE 68918453T DE 68918453 T DE68918453 T DE 68918453T DE 68918453 T2 DE68918453 T2 DE 68918453T2
Authority
DE
Germany
Prior art keywords
compositions based
peptides
cpf peptides
cpf
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68918453T
Other languages
English (en)
Other versions
DE68918453D1 (de
Inventor
Michael Zasloff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital of Philadelphia CHOP
Original Assignee
Childrens Hospital of Philadelphia CHOP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital of Philadelphia CHOP filed Critical Childrens Hospital of Philadelphia CHOP
Application granted granted Critical
Publication of DE68918453D1 publication Critical patent/DE68918453D1/de
Publication of DE68918453T2 publication Critical patent/DE68918453T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE68918453T 1988-10-21 1989-10-16 Zusammensetzungen auf Basis von CPF Peptiden sowie deren Verwendungen. Expired - Fee Related DE68918453T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26086188A 1988-10-21 1988-10-21
US36268989A 1989-06-07 1989-06-07
PCT/US1989/004625 WO1990004407A1 (en) 1988-10-21 1989-10-16 Cpf peptide compositions and uses

Publications (2)

Publication Number Publication Date
DE68918453D1 DE68918453D1 (de) 1994-10-27
DE68918453T2 true DE68918453T2 (de) 1995-02-23

Family

ID=26948228

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68918453T Expired - Fee Related DE68918453T2 (de) 1988-10-21 1989-10-16 Zusammensetzungen auf Basis von CPF Peptiden sowie deren Verwendungen.

Country Status (10)

Country Link
EP (1) EP0440688B1 (de)
JP (1) JPH04502901A (de)
KR (1) KR900701299A (de)
CN (1) CN1043874A (de)
AT (1) ATE111742T1 (de)
AU (1) AU4410989A (de)
CA (1) CA2001008A1 (de)
DE (1) DE68918453T2 (de)
IL (1) IL92030A (de)
WO (1) WO1990004407A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
CA2107674A1 (en) * 1991-04-08 1992-10-09 W. Lee Maloy Novel peptide compositions and uses therefor
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
GB9501300D0 (en) * 1995-01-24 1995-03-15 Boughton Brian J Peptides which inhibit viruses
US6057291A (en) 1995-06-02 2000-05-02 University Of British Columbia Antimicrobial cationic peptides
ES2316154T3 (es) 1995-08-23 2009-04-01 University Of British Columbia Peptidos cationicos antimicrobianos y procedimientos de seleccion de los mismos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507230A (en) * 1982-05-12 1985-03-26 Research Corporation Peptide synthesis reagents and method of use

Also Published As

Publication number Publication date
EP0440688B1 (de) 1994-09-21
KR900701299A (ko) 1990-12-01
ATE111742T1 (de) 1994-10-15
CN1043874A (zh) 1990-07-18
WO1990004407A1 (en) 1990-05-03
JPH04502901A (ja) 1992-05-28
EP0440688A1 (de) 1991-08-14
EP0440688A4 (en) 1992-07-08
CA2001008A1 (en) 1990-04-21
IL92030A (en) 1994-05-30
AU4410989A (en) 1990-05-14
DE68918453D1 (de) 1994-10-27

Similar Documents

Publication Publication Date Title
DE3866068D1 (de) Verhinderung der zahnsteinbildung durch polyanionische/hydrophobe peptide und deren derivate.
SE8903042D0 (sv) Pharmaceutical compositions comprising cyklosporins
DE68901417D1 (de) Pharmazeutische zusammensetzung.
NL960006I1 (nl) Purine-derivaten en de farmaceutische toepassing daarvan.
ATA154489A (de) Feste pharmazeutische ranitidinpraeparate
IT8747630A0 (it) Derivati di dicloroanilina, composizioni farmaceutiche che li contengono e procedimento per produrli
NZ220365A (en) Antiviral peptides and pharmaceutical compositions
DE3650733D1 (de) Pharmazeutische Zubereitungen und medizinische Verwendungen von Dioxopiperidinderivaten, insbesondere als Verstärker der Immunantwort sowie als antivirale und antibakterielle Wirkstoffe
DE3875108T2 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
FI893643A (fi) Farmaceutiska kompositioner.
DE3888197D1 (de) Gamma-interferon-formulierung.
DE68918453T2 (de) Zusammensetzungen auf Basis von CPF Peptiden sowie deren Verwendungen.
NZ234268A (en) Vasoactive intestinal peptide analogues, derivatives and pharmaceutical compositions
NO903844D0 (no) Medikamentavgivelsesblandinger basert paa biologiske celler eller komponenter derav og fremgangsmaater.
IT8621393A0 (it) Composizioni farmaceutiche ad azione vasodilatatrice e dantianossica.
IL90356A0 (en) Amphiphilic peptides and pharmaceutical compositions containing them
KR900701300A (ko) 생물학적 활성 펩티드 및 특정음이온을 갖는 조성물 및 이것을 사용하는 방법
IT8921567A0 (it) Derivati peptidici farmacologicamente attivi e preparazioni farmaceutiche che li contengono.
DE3782378T2 (de) Dihydropyridinderivate und deren pharmazeutische zusammensetzungen.
NO894594L (no) Farmasoeytiske sammensetninger omfattende labdan diterpenoid-derivater og pyrimido(6,1-a)isoquinolin-4-one-derivater.
EE9400337A (et) Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused
DE3866747D1 (de) Jod enthaltende pharmazeutische zubereitung.
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
DE3585936D1 (de) Biologisch aktive peptide, deren verfahren zur herstellung und pharmazeutische zusammensetzungen.
IT1264129B1 (it) Peptidi ad attivita' immunomodulatoria derivati da frammenti di leucochinina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee